Company / Gross Margin
NEUROONE MEDICAL TECHNOLOGIES Corp Gross Margin History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
31.3%
FY2025
5-year range
-54.9% / 31.3%
FY2021-FY2025
Trend
+33.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has increased for 3 consecutive years, from -54.9% in FY2022 to 31.3% in FY2025.
Based on SEC 10-K filings.
31.3% in FY2025 with a 3-year CAGR of +86.1%.
Improved from -41.4% to 31.3% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +86.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- NEUROONE MEDICAL TECHNOLOGIES Corp's gross margin has grown for 3 consecutive years.
- In FY2025, gross margin increased 33.7% year-over-year.
- Peak gross margin was recorded in FY2011.
- Lowest gross margin in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 31.3% | +33.7% |
| FY2024 | 23.4% | +156.5% |
| FY2023 | -41.4% | +24.6% |
| FY2022 | -54.9% | +0.0% |
| FY2021 | -54.9% | - |
| FY2016 | - | - |
| FY2015 | - | - |
| FY2014 | - | - |
| FY2012 | 60.4% | -39.6% |
| FY2011 | 100.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026